Rapporten
Dybdegående analyser af virksomhedsfinansiering, vækststrategier og markedsindsigt fra verdens mest innovative virksomheder
197 rapporter og tæller
NRG Therapeutics Raises $67M in Series B
NRG Therapeutics, a HealthTech company based in Cambridge, UK, has raised $67M in Series B from multiple investors.
NRG Therapeutics raises $67M Series B
NRG Therapeutics raises $67M in Series B. Developing treatments for ALS and neurodegenerative diseases...
NRG Therapeutics Raises $50M Series B to Transform Biotech
NRG Therapeutics has secured $50M Series B in funding to accelerate growth and innovation in the biotech sector. Gene therapy company developing treatments for Parkinson's disease and amyotrophic lateral sclerosis (ALS)...
Arnatar Therapeutics raises $52M Series A
Arnatar Therapeutics raises $52M in Series A. Developing therapeutics for autoimmune and inflammatory diseases...
Denali Therapeutics raises $217M Series C at $5B valuation
Denali Therapeutics raises $217M in Series C at $5B valuation. Neurodegeneration therapeutics...
Strand Therapeutics raises $153M Series B
Strand Therapeutics raises $153M in Series B. mRNA-based therapeutics developer with novel cancer treatment platform...
Seres Therapeutics raises $113M Series E at $450M valuation
Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...
Crystalys Therapeutics raises $205M Series B at $900M valuation
Crystalys Therapeutics raises $205M in Series B at $900M valuation. Developing novel therapeutics for neurodegenerative diseases...
Kailera Therapeutics raises $400M Series A at $1.5B valuation
Kailera Therapeutics raises $400M in Series A at $1.5B valuation. Developing obesity therapeutics with acquired pipeline...
Viser 9 rapporter • Side 1 • Kategori: all
Hold dig foran markedet
Få ugentlig indsigt leveret til din indbakke. Ingen spam, kun intelligens.